Galmed Pharmaceuticals Ltd. announced today that it will host a conference call and webcast on Wednesday, March 13, 2018, to provide an update on current developments with respect to its clinical programs for Aramchol™ and to discuss financial results for the quarter and year ended December 31, 2018.
March 6, 2019
· 1 min read